Tango Therapeutics, Inc.

CIK 1819133 · last filed 2021-12-10

Tango Therapeutics, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for BPMC, was dated Dec 10, 2021.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Blueprint Medicines Corp (BPMC) Delisted	Director	3,400	$129.46	$440.2K	$0	1	2021-12-10

Recent Filings

1 filing

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-12-10	Blueprint Medicines Corp (BPMC) Delisted	Grant (A)	+3,400	$0	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.